by Keishi Foecke | Apr 3, 2025 | Blog Post
The American life sciences ecosystem operates in one of the most complex and high-risk investment environments. With more than 80% of life sciences companies operating without a profit, external investment—including from venture capital (VC)—is often critical to...
by Keishi Foecke | Mar 25, 2025 | Blog Post
For decades, mergers and acquisitions (M&A) have fueled the development and delivery of breakthrough treatments for complex diseases with a high unmet need. A new resource from the Partnership for the U.S. Life Science Ecosystem (PULSE) spotlights this unique and...
by Keishi Foecke | Mar 19, 2025 | Blog Post
New resources from the Partnership for the U.S. Life Science Ecosystem (PULSE) highlight the unique and fundamental role of mergers and acquisitions (M&A) in America’s life sciences industry. Life sciences M&A represents a critical pathway for companies of all...
by Keishi Foecke | Mar 12, 2025 | Blog Post, PULSE Partner
In a recent op-ed for The Maryland Daily Record, Kelly Schulz, CEO of PULSE Partner Maryland Tech Council, discusses how federal policy against mergers and acquisitions (M&A) could undermine Maryland’s status as an innovation leader in the life sciences....
by Keishi Foecke | Mar 5, 2025 | Blog Post, Innovations Advanced by M&A
This blog is another installment in a series, Innovations Advanced by M&A, that underscores the unique role of mergers and acquisitions in promoting a competitive and innovative life sciences ecosystem for patients. You can find previous blogs in this...
by Keishi Foecke | Feb 26, 2025 | Blog Post
Competition policies that support pro-competitive mergers and acquisitions (M&A) are critical to fueling innovation, competition and growth in America’s life sciences industry. Importantly, M&A has a quantifiable impact for the ecosystem and for the thousands...
